Cite
HARVARD Citation
Coleman, C. et al. (2020). Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and coronary or peripheral artery disease. European heart journal. 6 (3), pp. 159-166. [Online].